Diaceutics PLC, established in 2005 and headquartered in Belfast, our global impact is powered by a dedicated 170-strong workforce spanning the globe.

Situated at the Kings Hall Health and Wellbeing Park in Belfast, we proudly contribute to placing Belfast on the global map as a centre of excellence in diagnostics. Our 2019 public listing attracted substantial global investment and venture capital, amplifying Northern Ireland’s prominence in IT, life sciences, and medical expertise, positioning the region as a Science and Innovation hub.

What sets us apart:

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. With an estimated positive impact on millions of patients, we provide the world’s leading pharma and biotech companies with commercialization solutions for precision medicines through real-world data analytics, engagement solutions and strategic advisory services enabled by our platform DXRX – The Diagnostic Network®

Engaging successfully with 40+ pharma companies and 2500 labs worldwide, we deliver tangible change for patients. Our unparalleled patient-level testing data and expansive lab network surpass any other company in healthcare. Diaceutics solutions assist the world’s largest pharma companies in commercializing precision medicines, maximizing return on investment, and ultimately, improving patients’ lives.

Proudly affiliated with Belfast Chamber, Diaceutics actively contributes to the dynamic growth and innovation of the life sciences sector in the vibrant city of Belfast.